Oxford COVID-19 vaccine trials produce robust immune response in elderly - FT

(Reuters) - Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca Plc, show it produces a robust immune response in elderly people, the group at highest risk,...